产品中心 抗体 其他一抗

所有图片(1/1)

Rat Anti-Mouse CD86/B7-2 Antibody (GL-1)

T-lymphocyte activation antigen CD86,Activation B7-2 antigen,B70,BU63,CTLA-4 counter-receptor B7.2,FUN-1

价格 600.00 供应商现货 : 3-5个工作日
货号 S0B0827
规格
数量
收藏 分享

产品介绍 FAQs 评论(0)

产品规格
  • 宿主来源

    Rat
  • 抗原名称

    CD86/B7-2
  • 分子别名

    T-lymphocyte activation antigen CD86, Activation B7-2 antigen, B70, BU63, CTLA-4 counter-receptor B7.2, FUN-1
  • 细胞定位

    Cell membrane
  • Accession

    P42081
  • 克隆号

    GL-1
  • 抗体类型

    Mouse mAb
  • 抗体同种型

    IgG2a,k
  • 反应种属 ?

    Ms
  • 纯化方式

    Protein G
  • 浓度

    2 mg/ml
  • 标记

    Unconjugated
  • 性状

    Liquid
  • 缓冲体系

    PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300

  • 储存条件

    12 months from date of receipt / reconstitution, -20 °C as supplied

  • 应用

    FCM

  • 稀释度

    应用 稀释度
    FCM 1:2000
背景介绍
  • CD86, also known as B7-2, is a crucial protein molecule in the immune system, belonging to the B7 protein family. This family comprises various costimulatory molecules that are essential for T-cell activation, proliferation, and the exertion of effector functions. CD86 provides the second signal (costimulatory signal) for T-cell activation by binding to the CD28 receptor on T-cells. This signal is necessary for the full activation and differentiation of T-cells into effector T-cells (e.g., Th1, Th2) or memory T-cells. CD86 also exerts a negative regulatory role through its interaction with the CTLA-4 receptor on T-cells. CTLA-4 has a higher affinity for CD86 than CD28, allowing it to competitively bind to CD86 during the later stages of T-cell activation, thereby inhibiting further T-cell activation and preventing excessive immune responses. CD86 also exerts a negative regulatory role through its interaction with the CTLA-4 receptor on T-cells. CTLA-4 has a higher affinity for CD86 than CD28, allowing it to competitively bind to CD86 during the later stages of T-cell activation, thereby inhibiting further T-cell activation and preventing excessive immune responses.

  • 流式分析

    • Flow cytometric analysis of C57BL/6 mouse splenocytes treated with 500ng/ml LPS for 3 days, labelling CD86/B7-2 antibody at 1/2000 (0.1 μg) dilution (Right) compared with a Mouse monoclonal IgG isotype control (Left). Then cells were stained with CD19 - PE/Cy7 separately. Goat Anti - Mouse IgG Alexa Fluor® 647 was used as the secondary antibody. Gated on total viable cells.

FAQs

斯达特公司的抗体,可以回收利用几次?

我们一般不推荐客户回收利用抗体。 因为抗体使用之后缓冲体系已经发生改变,不同客户在回收抗体的保存条件上也会有差异,所以抗体回收使用效果无法保证。另外,我们对一批抗体回收验证测试,测试结果显示不同抗体可回收次数不同,一般效价越高的抗体,可重复使用的次数越多,客户可根据实验情况来确定

评论(0)